 Todos Medical Ltd said 2021 was a strong year for the company, which saw it increase revenue by 136 to 12.28 million, compared to 5.21 million in 2020. Posting results for the full year and fourth quarter, ended December 31, 2021, the biotech noted that in the first nine months of 2021, revenue from Covid Testing and Tollovid increased by 492 to 7.7 million compared to 1.3 million in 2020. 